Dr. Sikander Ailawadhi
Claim this profileMayo Clinic in Florida
Expert in Multiple Myeloma
Expert in Plasma Cell Neoplasms
20 reported clinical trials
28 drugs studied
Area of expertise
1Multiple Myeloma
Global Leaderchr1q positive
del17p positive
Stage III
2Plasma Cell Neoplasms
Global Leaderchr1q positive
del17p positive
Stage III
Affiliated Hospitals
Clinical Trials Sikander Ailawadhi is currently running
CFT7455
for Lymphoma
The purpose of this study is to characterize the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of oral cemsidomide (also known as CFT7455) administered at different dosages in subjects with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM). Cemsidomide may be administered as a single agent and, in MM only, in combination with oral dexamethasone.
Recruiting1 award Phase 1 & 210 criteria
Combination Chemotherapy
for Multiple Myeloma
This phase II trial test whether combination chemotherapy works to improve blood test results in patients with high-risk multiple myeloma. Chemotherapy drugs, such as carfilzomib, daratumumab, lenalidomide, and dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help determine if patients who have a small amount of cancer left after the initial treatment, called minimal residual disease, will benefit from the drug combination.
Recruiting1 award Phase 218 criteria
More about Sikander Ailawadhi
Clinical Trial Related3 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Sikander Ailawadhi has experience with
- Lenalidomide
- Dexamethasone
- Bortezomib
- Pomalidomide
- Daratumumab
- Idecabtagene Vicleucel
Breakdown of trials Sikander Ailawadhi has run
Multiple Myeloma
Plasma Cell Neoplasms
Tumors
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sikander Ailawadhi specialize in?
Sikander Ailawadhi focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved chr1q positive patients, or patients who are del17p positive.
Is Sikander Ailawadhi currently recruiting for clinical trials?
Yes, Sikander Ailawadhi is currently recruiting for 10 clinical trials in Jacksonville Florida. If you're interested in participating, you should apply.
Are there any treatments that Sikander Ailawadhi has studied deeply?
Yes, Sikander Ailawadhi has studied treatments such as Lenalidomide, Dexamethasone, Bortezomib.
What is the best way to schedule an appointment with Sikander Ailawadhi?
Apply for one of the trials that Sikander Ailawadhi is conducting.
What is the office address of Sikander Ailawadhi?
The office of Sikander Ailawadhi is located at: Mayo Clinic in Florida, Jacksonville, Florida 32224 United States. This is the address for their practice at the Mayo Clinic in Florida.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.